Asclepia Capital
Research - New York, New York, United States
Asclepia Capital Employees
Asclepia Capital Details
The Asclepia Capital Fund, LP invests in innovative biotech and life science companies, or modern-day "healing temples," in the US and Europe. The Fund's fifteen to twenty-five holdings are growth in nature, and consist of companies balanced mostly across micro, small, and mid capitalizations, undergoing a rigorous due diligence process based on bottom-up style of analysis. With a contrarian and deep-value based investing philosophy, Asclepia identifies core holdings that consist of companies largely under-the-radar, unloved, underappreciated, and undervalued by the investment community. They also obtain price target objectives within a twelve-to-eighteen month timeframe. While core holdings may experience volatility along the way, performance volatility is mitigated by trading positions, which consist of companies with a three-to-six month timeframe and an undervalued thesis based on more than just fundamental reasons. This mix of core holdings and trading positions are hedged by a basket of short positions and/or index options and allow us to maintain a competitive advantage over our peers in both up and down markets.
Asclepia Capital Technologies
Load Balancers
Varnish
CMS
Wix
Other
Mobile Friendly